Related Experiment Video
Updated: Aug 8, 2026

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
Published on: April 2, 2013
Parachlamydia acanthamoebae enters and multiplies within pneumocytes and lung fibroblasts
Nicola Casson1, Noël Medico, Jacques Bille
1Center for Research on Intracellular Bacteria, Microbiology Institute, Faculty of Biology and Medicine, University of Lausanne, Bugnon 48, 1011 Lausanne, Switzerland.
Abstract:
Parachlamydia acanthamoebae is a Chlamydia-like organism that naturally infects free-living amoebae. P. acanthamoebae is a putative emerging agent of community-acquired and inhalation pneumonia that may enter and multiply within human macrophages. However, since Parachlamydia induces their apoptosis, macrophages may not represent a perennial niche for this obligate intracellular bacterium. Therefore, we investigated whether pneumocytes and lung fibroblasts are permissive to Parachlamydia infection and might act as a replicative niche. Entry of Parachlamydia into pneumocytes (A549) and lung fibroblasts (HEL) was confirmed by confocal and electron microscopy. In A549 cells, the mean number of Parachlamydia per cell increased 7-fold from day 0 to day 7, independently of the technique used to label the bacteria. The proportion of infected A549 cells also increased over time, whereas cell viability remained unaffected by Parachlamydia infection. The sustained (3 weeks) viability of Parachlamydia when incubated in the presence of A549 cells contrasted with that observed in the absence of cells. HEL cells were also permissive to Parachlamydia infection, as we observed a 3- to 4-fold increase in the mean number of bacteria per cell. In HEL cells, Parachlamydia retained some viability for 2 weeks. These findings demonstrate that Parachlamydia is able to enter and multiply within pneumocytes and fibroblasts. The viability of both cell types was not compromised after Parachlamydia infection. We therefore conclude that these cells may remain infected for a prolonged time and may represent an intrapulmonary niche for the strictly intracellular Parachlamydia. This indirectly supports the role of Parachlamydia as an agent of pneumonia.
Insights
Parachlamydia acanthamoebae can infect and multiply in lung pneumocytes and fibroblasts, suggesting these cells serve as a prolonged intrapulmonary niche for this pneumonia-causing bacterium.
Area of Science:
- Microbiology
- Cell Biology
- Infectious Diseases
Background:
- Parachlamydia acanthamoebae is a Chlamydia-like organism known to infect amoebae.
- It is a potential emerging cause of community-acquired and inhalation pneumonia.
- Macrophages are infected but undergo apoptosis, questioning their role as a long-term niche.
Purpose of the Study:
- To investigate if human pneumocytes and lung fibroblasts are permissive to Parachlamydia acanthamoebae infection.
- To determine if these cells can serve as a replicative niche for the bacterium.
Main Methods:
- Confocal and electron microscopy were used to confirm bacterial entry into A549 (pneumocytes) and HEL (fibroblasts) cells.
- Bacterial load and cell viability were assessed over time.
- Bacterial survival in the presence and absence of host cells was compared.
Main Results:
- Parachlamydia acanthamoebae successfully entered and replicated within both pneumocytes and fibroblasts.
- A 7-fold increase in bacteria within pneumocytes and a 3- to 4-fold increase in fibroblasts were observed.
- Host cell viability remained unaffected, and bacteria showed sustained viability for up to 3 weeks in the presence of pneumocytes.
Conclusions:
- Pneumocytes and lung fibroblasts are permissive to Parachlamydia acanthamoebae infection.
- These cells can act as a prolonged intrapulmonary niche for the bacterium.
- Findings support the role of Parachlamydia acanthamoebae as an agent of pneumonia.
More Related Videos
09:04Discovery of New Intracellular Pathogens by Amoebal Coculture and Amoebal Enrichment Approaches
Published on: October 27, 2013
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
Related Concept Videos
Bacterial Phylum Chlamydiae
Atypical Pneumonia
Amebiasis
Leishmaniasis
Diversity of Protists II
Trichomoniasis